Chemoinformaics analysis of 20-Dihydroxy-30-norlupane
| Molecular Weight | 460.699 | nRot | 2 |
| Heavy Atom Molecular Weight | 412.315 | nRig | 26 |
| Exact Molecular Weight | 460.355 | nRing | 5 |
| Solubility: LogS | -3.994 | nHRing | 0 |
| Solubility: LogP | 4.745 | No. of Aliphatic Rings | 5 |
| Acid Count | 1 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 5 |
| Atoms Count | 81 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 33 | No. of Aromatic Carbocycles | 0 |
| nHetero | 4 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 5 |
| No. of Hydrogen atom | 48 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 29 | No. of Saturated Rings | 5 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 4 | No. of Arom Bond | 0 |
| nHA | 3 | APOL | 83.6441 |
| nHD | 3 | BPOL | 49.0219 |
| QED | 0.48 |
| Synth | 4.801 |
| Natural Product Likeliness | 2.944 |
| NR-PPAR-gamma | 0.782 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.004 |
| Pgp-sub | 0 |
| HIA | 0.025 |
| CACO-2 | -5.22 |
| MDCK | 0.0000282 |
| BBB | 0.628 |
| PPB | 0.972909 |
| VDSS | 0.949 |
| FU | 0.0334753 |
| CYP1A2-inh | 0.007 |
| CYP1A2-sub | 0.497 |
| CYP2c19-inh | 0.011 |
| CYP2c19-sub | 0.944 |
| CYP2c9-inh | 0.101 |
| CYP2c9-sub | 0.719 |
| CYP2d6-inh | 0.001 |
| CYP2d6-sub | 0.457 |
| CYP3a4-inh | 0.048 |
| CYP3a4-sub | 0.219 |
| CL | 3.277 |
| T12 | 0.051 |
| hERG | 0.016 |
| Ames | 0.018 |
| ROA | 0.127 |
| SkinSen | 0.05 |
| Carcinogencity | 0.01 |
| EI | 0.015 |
| Respiratory | 0.904 |
| NR-Aromatase | 0.082 |
| Antiviral | No |
| Prediction | 0.668071 |